Valneva confirmed its outlook for 2025, including expectations for total revenue between 180 million and 190 million euros. Total revenue last year was approximately 170 million euros. With Pfizer, ...

With the American consumer running out of breath amid an economic slowdown in the second half of 2025, Stifel sees a selloff of 10% or more in the S&P 500.

Stifel’s Barry Bannister says stocks are due for a big drop and thinks investors should play defense with staples and ...

Fintel reports that on August 8, 2025, Stifel downgraded their outlook for Crocs (NasdaqGS:CROX) from Buy to Hold. Analyst ...

Alcon Inc. (NYSE:ALC) ranks among the best medical stocks to buy according to analysts. On July 10, Stifel reaffirmed its Buy ...

Stifel’s reaffirmation arrives even after a rough stretch for NOV: recent quarterly earnings have disappointed, with flat to ...

The St. Louis-based investment banker and wealth manager saw a brisk second half of the quarter after the fallout from the ...

After a difficult start to the year, Stifel reported a strong second quarter, with record AUM and net revenue figures for its wealth management division.

Stifel Financial Corp.'s Chief Executive Ronald James Kruszewski on Wednesday warned of a "brief pullback" in financial markets due to more speculative behavior of late. "We've seen a reemergence of ...

Discover key insights from Stifel Financial's record-breaking Q2 2025, including asset growth, robust recruiting, strategic shifts, and a promising outlook.

Stifel Financial Corp. ( NYSE: SF) Q2 2025 Earnings Conference Call July 30, 2025 9:30 AM ET James M. Marischen - Senior VP & CFO Joel Michael Jeffrey - Senior Vice President of Investor relations ...